New Medicare Benefits Schedule (MBS) item for faecal calprotectin testing
From 1 November 2025 patients diagnosed with IBD who are symptomatic will be able to access a Medicare benefit for a faecal test to support the management of their condition.
The new item allows practitioners to request a Medicare funded pathology service for symptomatic diagnosed IBD patients to inform the management of their disease.
Thank you to the CCA community for providing important feedback into this approval.